Stockholders' Equity |
Shareholders’ Equity The following tables summarize our shareholders’ equity activity for the three months ended March 31, 2024 and March 31, 2023, respectively: | | | | | | | | | | | | | | | | | | | | | | | | | | | Millions of dollars | Common Stock | Paid-in Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | Total | Balance at December 31, 2023 | $ | 2,663 | | $ | 63 | | $ | (5,540) | | $ | 12,536 | | $ | (331) | | $ | 42 | | $ | 9,433 | | Comprehensive income (loss): | | | | | | | | Net income | — | | — | | — | | 606 | | — | | 3 | | 609 | | Other comprehensive income (loss) | — | | — | | — | | — | | (1) | | 1 | | — | | Cash dividends ($0.17 per share) | — | | — | | — | | (151) | | — | | — | | (151) | | Stock repurchase program | — | | — | | (250) | | — | | — | | — | | (250) | | Stock plans (a) | (1) | | (63) | | 108 | | (3) | | — | | — | | 41 | | Other | — | | — | | — | | — | | — | | — | | — | | Balance at March 31, 2024 | $ | 2,662 | | $ | — | | $ | (5,682) | | $ | 12,988 | | $ | (332) | | $ | 46 | | $ | 9,682 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (a) | In the first quarter of 2024, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. As a result, additional paid in capital was reduced to zero, which resulted in a reduction of retained earnings by $3 million. Future issuances from treasury shares could similarly impact additional paid in capital and retained earnings. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Millions of dollars | Common Stock | Paid-in Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | Total | Balance at December 31, 2022 | $ | 2,664 | | $ | 50 | | $ | (5,108) | | $ | 10,572 | | $ | (230) | | $ | 29 | | $ | 7,977 | | Comprehensive income (loss): | | | | | | | | Net income | — | | — | | — | | 651 | | — | | 4 | | 655 | | Other comprehensive income | — | | — | | — | | — | | 1 | | — | | 1 | | Cash dividends ($0.16 per share) | — | | — | | — | | (145) | | — | | — | | (145) | | Stock repurchase program | — | | — | | (100) | | — | | — | | — | | (100) | | Stock plans (a) | — | | (50) | | 113 | | (3) | | — | | — | | 60 | | Other | — | | — | | — | | — | | — | | (3) | | (3) | | Balance at March 31, 2023 | $ | 2,664 | | $ | — | | $ | (5,095) | | $ | 11,075 | | $ | (229) | | $ | 30 | | $ | 8,445 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (a) | In the first quarter of 2023, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. As a result, additional paid in capital was reduced to zero, which resulted in a reduction of retained earnings by $3 million. Future issuances from treasury shares could similarly impact additional paid in capital and retained earnings. |
Our Board of Directors has authorized a program to repurchase our common stock from time to time. We repurchased 7.0 million shares of our common stock under the program during the three months ended March 31, 2024 for approximately $250 million. Approximately $3.8 billion remained authorized for repurchases as of March 31, 2024. From the inception of this program in February of 2006 through March 31, 2024, we repurchased approximately 260 million shares of our common stock for a total cost of approximately $10.3 billion. We repurchased 2.9 million shares of our common stock under the program during the three months ended March 31, 2023 for approximately $100 million. Accumulated other comprehensive loss consisted of the following: | | | | | | | | | | | | Millions of dollars | March 31, 2024 | December 31, 2023 | Cumulative translation adjustments | $ | (83) | | $ | (84) | | Defined benefit and other postretirement liability adjustments | (210) | | (207) | | | | | | Other | (39) | | (40) | | Total accumulated other comprehensive loss | $ | (332) | | $ | (331) | | | | | | | |
|